Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019;7(4):314-327.
doi: 10.2174/2211738507666190726162000.

A Novel Approach of Drug Localization through Development of Polymeric Micellar System Containing Azelastine HCl for Ocular Delivery

Affiliations

A Novel Approach of Drug Localization through Development of Polymeric Micellar System Containing Azelastine HCl for Ocular Delivery

Sheetal Devi et al. Pharm Nanotechnol. 2019.

Abstract

Background: Development of polymeric micelles for the management of allergic conjunctivitis to overcome the limitations of topical installation, such as poor patient compliance, poor stromal permeability, and significant adverse effects, increase precorneal residence time and efficacy, and also control the release of drug at the target site.

Objective: The investigation was aimed at developing a polymeric micellar system of Azelastine HCl for Ocular Delivery.

Methods: Drug loaded micelles of tri-block copolymers Pf 127 were prepared by Thin Film hydration method. The polymeric micelles formulations (F1 to F9) were assessed for entrapment efficiency, micelle size, in vitro permeation, ex vivo transcorneal permeation, in vivo Ocular Irritation, and Histology.

Results: Optimized micelles formulation (F3), with the lowest micelle size of 92 nm, least polydispersity value of 0.135, highest entrapment efficiency of 95.30 ± 0.17%, and a cumulative drug permeation of 84.12 ± 1.26% in 8h, was selected to develop pH-sensitive micelles loaded carbopol in situ gel. The optimized in situ gel (G4) proved to be superior in its ex vivo transcorneal permeation when compared with Market Preparation and pure drug suspension, exhibiting 43.35 ± 1.48% Permeation with zero-order kinetics (r2 = 0.9944) across goat cornea. Transmission Electron microscopy revealed spherical polymeric micelles trapped in the gel matrix. A series of experiments showed hydration capability, non-irritancy, and histologically safe gel formulation that had appropriate handling characteristics.

Conclusion: A controlled release pH-sensitive ocular formulation capable of carrying the drug to the anterior section of the eye via topical delivery was successfully developed for the treatment of allergic conjunctivitis.

Keywords: Azelastine HCl; entrapment efficiency; ex vivo transcorneal permeation; histology; in vitro permeation; in vivo ocular irritation; transmission electron microscopy; tri-block copolymers..

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
CMC determination of Pf 127 using Sudan III dye.
Fig. (2)
Fig. (2)
DSC thermogram of Pluronic F-127, Azelastine HCl loaded polymeric micelles (F3) and Azelastine HCl.
Fig. (3)
Fig. (3)
Comparative in vitro drug permeation profiles of Azelastine HCl from developed polymeric micelles (F1-F9) and pure drug suspension in STF pH 7.4 using Franz diffusion cell.
Fig. (4)
Fig. (4)
TEM image of optimized Azelastine HCl polymeric micelles (F3).
Fig. (5)
Fig. (5)
Comparative ex vivo drug permeation profiles of Azelastine HCl loaded polymeric micelles (F3), Micelle loaded in situ gel (G4), Marketed preparation (MP) and Azelastine HCl pure drug suspension in STF pH 7.4 using Franz diffusion cell.
Fig. (6)
Fig. (6)
Histological cross section of excised goat cornea, (a) PBS pH 7.4 (negative control) (b) 75% isopropyl alcohol (positive control), (c) G4.

Similar articles

Cited by

References

    1. Kuno N., Fujii S. Recent advances in ocular drug delivery systems. Polymers (Basel) 2011;3(1):193–221.
    1. Danion A., Arsenault I., Vermette P. Antibacterial activity of contact lenses bearing surface-immobilized layers of intact liposomes loaded with levofloxacin. J. Pharm. Sci. 2007;96(9):2350–2363. - PubMed
    1. Lavik E., Kuehn M.H., Kwon Y.H. Novel drug delivery systems for glaucoma. Eye (Lond.) 2011;25(5):578–586. - PMC - PubMed
    1. Short B.G. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol. Pathol. 2008;36(1):49–62. - PubMed
    1. Gulsen D., Chauhan A. Ophthalmic drug delivery through contact lenses. Invest. Ophthalmol. Vis. Sci. 2004;45(7):2342–2347. - PubMed